|Each vial contains:
- Sodium valproate is indicated as an intravenous (IV) alternative in patients for whom oral administration of valproate products is temporarily not feasible in the following conditions:
- Monotheraphy and adjunctive therapy in the treatment of patients with complex partial seizures that occurs either in isolation or in association with other types of seizures.
- Monotheraphy and adjunctive therapy in the treatment of patients with simple and complex absence seizures, and adjunctively in patients with multiple seizure types that include absence seizures.
Dosage and Administration
For more information on safety, precaution and other information about this product, please see the Product Insert.
Please consult your physician and other healthcare providers before taking any prescription medicines found on this site. The contents found on this page are for information purposes only. It should not be construed as a substitute for professional medical advise and should not be relied upon in that regard. You undertake to carefully read all product packaging and labels prior to use.
Caution: Food, Drugs, Devices and Cosmetics Act prohibits dispensing without prescription.